Important Cogent Update
The Summit Clinical Trial for Nonadvanced Systemic Mastocytosis has completed enrollment. The Apex Clinical Trial for Advanced Systemic Mastocytosis has limited screening slots available for people diagnosed with SM-AHN.
To receive the latest updates from Cogent on Systemic Mastocytosis research, treatment developments, and educational resources, please sign-up now.
About Systemic Mastocytosis
Systemic Mastocytosis (SM) is a rare disorder characterized by the accumulation of abnormal mast cells in various organs, including the skin, bone marrow, liver, and spleen. Symptoms vary based on the disease subtype and can range from skin lesions and gastrointestinal issues to severe allergic reactions and organ dysfunction.
If you have questions about access to a Cogent investigational therapy, please speak with your doctor or email trialinfo@cogentbio.com.
Sign up to stay informed about Systemic Mastocytosis (SM) research and treatment information.
- Up-to-date research and treatment information
- Tools to help empower you in your experience living with Systemic Mastocytosis
- Educational resources and tools to help strengthen your knowledge and understanding of SM
For U.S. residents only
By submitting this form, I agree that Cogent Biosciences may use the information I’m submitting to provide me with the information I requested and other related information, including services or programs that Cogent Biosciences offers, sponsors or other topics of interest. I understand that all my personal information will be used only under Cogent Biosciences’ Privacy Policy, and I agree with Cogent Biosciences’ Terms of Use. I understand I can unsubscribe at any time.